{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:41:38Z","timestamp":1791315698708,"version":"4.3.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose of Review<\/jats:title><jats:p>Sudden cardiac death is recognised as a devastating consequence of non-ischaemic dilated cardiomyopathy. Although implantable cardiac defibrillators offer protection against some forms of sudden death, the identification of patients in this population most likely to benefit from this therapy remains challenging and controversial. In this review, we evaluate current guidelines and explore established and novel predictors of sudden cardiac death in patients with non-ischaemic dilated cardiomyopathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent Findings<\/jats:title><jats:p>Current international guidelines for primary prevention implantable defibrillator therapy do not result in improved longevity for many patients with non-ischemic cardiomyopathy and severe left ventricular dysfunction. More precise methods for identifying higher-risk patients that derive true prognostic benefit from this therapy are required.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Dynamic and multi-parametric characterization of myocardial, electrical, serological and genetic substrate offers novel strategies for predicting major arrhythmic risk. Balancing the risk of non-sudden death offers an opportunity to personalize therapy and avoid unnecessary device implantation for those less likely to derive benefit.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11886-020-01343-9","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T08:08:43Z","timestamp":1594282123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach"],"prefix":"10.1007","volume":"22","author":[{"given":"Daniel J.","family":"Hammersley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-1748","authenticated-orcid":false,"given":"Brian P.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"1343_CR1","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, B\u00f6hm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850\u20138.","journal-title":"Eur Heart J"},{"key":"1343_CR2","doi-asserted-by":"publisher","unstructured":"Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol [internet] Nature Publishing Group; 2013;10:531\u2013547. https:\/\/doi.org\/10.1038\/nrcardio.2013.105","DOI":"10.1038\/nrcardio.2013.105"},{"key":"1343_CR3","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134.","DOI":"10.1161\/CIR.0000000000000455"},{"key":"1343_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams","year":"2005","unstructured":"Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209\u201316.","journal-title":"Am Heart J"},{"key":"1343_CR5","doi-asserted-by":"crossref","unstructured":"Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med [Internet]. 2000;342:1077\u201384. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10760308.","DOI":"10.1056\/NEJM200004133421502"},{"key":"1343_CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ejhf.16","volume":"16","author":"M Merlo","year":"2014","unstructured":"Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30\u00a0years methods and results conclusions an effective management and evidence-based integrated therapeutic approach. Eur J Heart Fail. 2014;16:317\u201324.","journal-title":"Eur J Heart Fail"},{"key":"1343_CR7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129\u20132200m.","journal-title":"Eur Heart J"},{"key":"1343_CR8","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. ACCF\/AHA guideline for the management of heart failure. J Am Coll Cardiol [Internet]. Elsevier 2013; 62:e147\u2013239. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713021141."},{"key":"1343_CR9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","volume":"21","author":"SJ Connolly","year":"2000","unstructured":"Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Metal-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J. 2000;21:2071\u20138.","journal-title":"Eur Heart J"},{"key":"1343_CR10","doi-asserted-by":"crossref","unstructured":"Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Personalizing risk stratification for sudden death in dilated cardiomyopathy: the past, present, and future. Circulation [Internet]. 2017;136:215\u201331. Available from: http:\/\/circ.ahajournals.org\/lookup\/doi\/10.1161\/CIRCULATIONAHA.116.027134.","DOI":"10.1161\/CIRCULATIONAHA.116.027134"},{"key":"1343_CR11","doi-asserted-by":"crossref","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med [Internet]. 2005;352:225\u201337. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15659722.","DOI":"10.1056\/NEJMoa043399"},{"key":"1343_CR12","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","volume":"350","author":"A Kadish","year":"2004","unstructured":"Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151\u20138.","journal-title":"N Engl J Med"},{"key":"1343_CR13","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","volume":"41","author":"SA Strickberger","year":"2003","unstructured":"Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol. 2003;41:1707\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","volume":"105","author":"D B\u00e4nsch","year":"2002","unstructured":"B\u00e4nsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002;105:1453\u20138.","journal-title":"Circulation."},{"key":"1343_CR15","doi-asserted-by":"crossref","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol [internet]. 2013;62:e147-239. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23747642.","DOI":"10.1161\/CIR.0b013e31829e8776"},{"key":"1343_CR16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","volume":"12","author":"DAMJ Theuns","year":"2010","unstructured":"Theuns DAMJ, Smith T, Hunink MGM, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace. 2010;12:1564\u201370.","journal-title":"Europace."},{"key":"1343_CR17","doi-asserted-by":"crossref","unstructured":"K\u00f8ber L, Thune JJ, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskj\u00e6r H, Brandes A, Th\u00f8gersen AM, Gustafsson F, Egstrup K, Videb\u00e6k R, Hassager C, Svendsen JH, H\u00f8fsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med [Internet] 2016;375:1221\u20131230. Available from: http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1608029","DOI":"10.1056\/NEJMoa1608029"},{"key":"1343_CR18","doi-asserted-by":"crossref","unstructured":"Wolff G, Lin Y, Karathanos A, Brockmeyer M, Wolters S, Nowak B, et al. Implantable cardioverter\/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials Clin Res Cardiol. Springer Berlin Heidelberg; 2017;106:501\u2013513.","DOI":"10.1007\/s00392-017-1079-0"},{"key":"1343_CR19","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, et al. Declining risk of sudden death in heart failure. N Engl J Med. 2017;377:41\u201351. This study demonstrates that there has been a substantial decline in the rates of sudden cardiac death in patients with heart failure and reduced ejection fraction enrolled in clinical trials over the past 20\u00a0years.","DOI":"10.1056\/NEJMoa1609758"},{"key":"1343_CR20","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 K\u00f8ber L, Thune JJ, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221\u201330. The major finding from this study was that primary prevention ICD therapy for symptomatic patients with systolic heart failure on contemporary medical treatment was not associated with improved longevity.","DOI":"10.1056\/NEJMoa1608029"},{"key":"1343_CR21","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.114.011283","volume":"130","author":"MH Ruwald","year":"2014","unstructured":"Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, et al. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy. Circulation. 2014;130:2278\u201386.","journal-title":"Circulation."},{"key":"1343_CR22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCEP.112.000214","volume":"6","author":"JA Manfredi","year":"2013","unstructured":"Manfredi JA, Al-Khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, et al. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Circ Arrhythmia Electrophysiol. 2013;6:257\u201364.","journal-title":"Circ Arrhythmia Electrophysiol."},{"key":"1343_CR23","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/eurheartj\/ehv373","volume":"36","author":"NA Chatterjee","year":"2015","unstructured":"Chatterjee NA, Roka A, Lubitz SA, Gold MR, Daubert C, Linde C, et al. Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review. Eur Heart J. 2015;36:2780\u20139.","journal-title":"Eur Heart J"},{"key":"1343_CR24","doi-asserted-by":"publisher","unstructured":"Schliamser JE, Kadish AH, Subacius H, Shalaby A, Schaechter A, Levine J, Goldberger JJ, DEFINITE Investigators Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE). Hear Rhythm [Internet]. Elsevier; 2013;10:838\u2013846. https:\/\/doi.org\/10.1016\/j.hrthm.2013.02.017","DOI":"10.1016\/j.hrthm.2013.02.017"},{"key":"1343_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","volume":"116","author":"D Mozaffarian","year":"2007","unstructured":"Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JGF, et al. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation. 2007;116:392\u20138.","journal-title":"Circulation."},{"key":"1343_CR26","doi-asserted-by":"publisher","unstructured":"Halliday BP, Lota AS, Prasad SK. Sudden death risk markers for patients with left ventricular ejection fractions greater than 40%. Trends Cardiovasc Med [Internet]. Elsevier Inc.; 2018;28:516\u201321. https:\/\/doi.org\/10.1016\/j.tcm.2018.05.001.","DOI":"10.1016\/j.tcm.2018.05.001"},{"key":"1343_CR27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jacc.2017.07.748","volume":"70","author":"JGF Cleland","year":"2017","unstructured":"Cleland JGF, Halliday BP, Prasad SK. Selecting patients with nonischemic dilated cardiomyopathy for ICDs: myocardial function, fibrosis, and what\u2019s attached? J Am Coll Cardiol. 2017;70:1228\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0195-668X(03)00191-X","volume":"24","author":"APM Gorgels","year":"2003","unstructured":"Gorgels APM, Gijsbers C, De Vreede-Swagemakers J, Lousberg A, Wellens HJJ. Out-of-hospital cardiac arrest - the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J. 2003;24:1204\u20139.","journal-title":"Eur Heart J"},{"key":"1343_CR29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","volume":"47","author":"EC Stecker","year":"2006","unstructured":"Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon sudden unexpected death study. J Am Coll Cardiol. 2006;47:1161\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR30","first-page":"1","volume":"3","author":"FM Merchant","year":"2014","unstructured":"Merchant FM, Jones P, Wehrenberg S, Lloyd MS, Saxon LA. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assoc. 2014;3:1\u20137.","journal-title":"J Am Heart Assoc"},{"key":"1343_CR31","unstructured":"\u2022 Elming MB, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, Signorovitch J, et al. Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure. Circulation. 2017;136:1772\u201380. This study demonstrated that the association between primary prevention ICD implantation and survival decreased linearly with increasing age for patients in DANISH. The age of 70 may represent the optimal cut off for recommending ICD therapy."},{"key":"1343_CR32","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424\u201333.","journal-title":"Circulation."},{"key":"1343_CR33","doi-asserted-by":"publisher","unstructured":"Shadman R, Poole JE, Dardas TF, Mozaffarian D, Cleland JGF, Swedberg K, Maggioni AP, Anand IS, Carson PE, Miller AB, Levy WC A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Hear Rhythm [Internet]. Elsevier; 2015;12:2069\u20132077. Available from: https:\/\/doi.org\/10.1016\/j.hrthm.2015.06.039","DOI":"10.1016\/j.hrthm.2015.06.039"},{"key":"1343_CR34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jchf.2019.03.019","volume":"7","author":"SL Kristensen","year":"2019","unstructured":"Kristensen SL, Levy WC, Shadman R, Nielsen JC, Haarbo J, Videb\u00e6k L, et al. Risk models for prediction of implantable cardioverter-defibrillator benefit: insights from the DANISH trial. JACC Hear Fail. 2019;7:717\u201324.","journal-title":"JACC Hear Fail"},{"key":"1343_CR35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jchf.2019.05.011","volume":"7","author":"JP Daubert","year":"2019","unstructured":"Daubert JP, Barnett AS. Primary prevention implantable cardioverter-defibrillators in patients with nonischemic cardiomyopathy. JACC Hear Fail. 2019;7:725\u20137.","journal-title":"JACC Hear Fail."},{"key":"1343_CR36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","volume":"108","author":"JA McCrohon","year":"2003","unstructured":"McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54\u20139.","journal-title":"Circulation."},{"key":"1343_CR37","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","volume":"48","author":"RG Assomull","year":"2006","unstructured":"Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977\u201385.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR38","doi-asserted-by":"crossref","unstructured":"Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. J Am Med Assoc [Internet]. 2013;309:896\u2013908. Available from: http:\/\/jama.jamanetwork.com\/article.aspx?articleid=1660382.","DOI":"10.1001\/jama.2013.1363"},{"key":"1343_CR39","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jcmg.2013.05.013","volume":"6","author":"TG Neilan","year":"2013","unstructured":"Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:944\u201354.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1343_CR40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.113.000996","volume":"7","author":"PG Masci","year":"2014","unstructured":"Masci PG, Doulaptsis C, Bertella E, Del Torto A, Symons R, Pontone G, et al. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Hear Fail. 2014;7:448\u201356.","journal-title":"Circ Hear Fail"},{"key":"1343_CR41","doi-asserted-by":"publisher","unstructured":"Leyva F, Taylor RJ, Foley PWX, Umar F, Mulligan LJ, Patel K, et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol [Internet]. Elsevier Inc.; 2012;60:1659\u201367. https:\/\/doi.org\/10.1016\/j.jacc.2012.05.054","DOI":"10.1016\/j.jacc.2012.05.054"},{"key":"1343_CR42","unstructured":"Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc Imaging [Internet]. 2018; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30219397."},{"key":"1343_CR43","unstructured":"\u2022 Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135:2106\u201315. This study demonstrates that mid-wall LGE identifies a group of patients with DCM and an LVEF \u2265\u200940% who are at increased risk of SCD with a lower risk of non-sudden death. Such patients are likely to derive benefit from primary prevention ICD therapy, yet this practice is not supported by current guidelines, illustrating the need for their refinement."},{"key":"1343_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.01832","volume":"9","author":"G Balaban","year":"2018","unstructured":"Balaban G, Halliday BP, Mendonca Costa C, Bai W, Porter B, Rinaldi CA, et al. Fibrosis microstructure modulates reentry in non-ischemic dilated cardiomyopathy: insights from imaged guided 2D computational modeling. Front Physiol. 2018;9:1\u201313.","journal-title":"Front Physiol"},{"key":"1343_CR45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jcmg.2018.07.003","volume":"12","author":"RG Muthalaly","year":"2019","unstructured":"Muthalaly RG, Kwong RY, John RM, van der Geest RJ, Tao Q, Schaeffer B, et al. Left ventricular entropy is a novel predictor of arrhythmic events in patients with dilated cardiomyopathy receiving defibrillators for primary prevention. JACC Cardiovasc Imaging. 2019;12:1177\u201384.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1343_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12410-015-9363-8","volume":"9","author":"G Pontone","year":"2016","unstructured":"Pontone G, Guaricci AI, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, et al. Prognostic benefit of cardiac magnetic resonance over transthoracic echocardiography for the assessment of ischemic and nonischemic dilated cardiomyopathy patients referred for the evaluation of primary prevention implantable cardioverter-defibrillator Th. Circ Cardiovasc Imaging. 2016;9:1\u201311.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1343_CR47","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","volume":"52","author":"L Iles","year":"2008","unstructured":"Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","volume":"9","author":"VO Puntmann","year":"2016","unstructured":"Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, et al. T1-mapping and outcome in nonischemic cardiomyopathy all-cause mortality and heart failure. JACC Cardiovasc Imaging. 2016;9:40\u201350.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1343_CR49","doi-asserted-by":"publisher","unstructured":"Chen Z, Sohal M, Voigt T, Sammut E, Tobon-Gomez C, Child N, Jackson T, Shetty A, Bostock J, Cooklin M, O\u2019Neill M, Wright M, Murgatroyd F, Gill J, Carr-White G, Chiribiri A, Schaeffter T, Razavi R, Rinaldi CA Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators. Hear Rhythm [Internet]. Elsevier; 2015;12:792\u2013801. https:\/\/doi.org\/10.1016\/j.hrthm.2014.12.020","DOI":"10.1016\/j.hrthm.2014.12.020"},{"key":"1343_CR50","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1161\/CIRCULATIONAHA.107.754424","volume":"118","author":"G Buckberg","year":"2008","unstructured":"Buckberg G, Hoffman JIE, Mahajan A, Saleh S, Coghlan C. Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation. 2008;118:2571\u201387.","journal-title":"Circulation."},{"key":"1343_CR51","doi-asserted-by":"publisher","unstructured":"Brown J, Jenkins C, Marwick TH. Use of myocardial strain to assess global left ventricular function: a comparison with cardiac magnetic resonance and 3-dimensional echocardiography. Am Heart J [Internet]. Mosby, Inc.; 2009;157:102.e1\u2013102.e5. https:\/\/doi.org\/10.1016\/j.ahj.2008.08.032","DOI":"10.1016\/j.ahj.2008.08.032"},{"key":"1343_CR52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ehjci\/jeu181","volume":"16","author":"SJ Buss","year":"2015","unstructured":"Buss SJ, Breuninger K, Lehrke S, Voss A, Galuschky C, Lossnitzer D, et al. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2015;16:307\u201315.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1343_CR53","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.echo.2010.07.019","volume":"23","author":"A Mignot","year":"2010","unstructured":"Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C, et al. Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr. 2010;23:1019\u201324.","journal-title":"J Am Soc Echocardiogr"},{"key":"1343_CR54","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2013.02.061","volume":"61","author":"M Ersb\u00f8ll","year":"2013","unstructured":"Ersb\u00f8ll M, Valeur N, Mogensen UM, Andersen MJ, M\u00f8ller JE, Velazquez EJ, et al. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2013;61:2365\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR55","doi-asserted-by":"publisher","unstructured":"Romano S, Judd RM, Kim RJ, Kim HW, Klem I, Heitner JF, et al. Feature-tracking global longitudinal strain predicts death in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy incremental to ejection fraction and late gadolinium enhancement. JACC Cardiovasc Imaging [Internet]. 2018; https:\/\/doi.org\/10.1016\/j.jcmg.2017.10.024.","DOI":"10.1016\/j.jcmg.2017.10.024"},{"key":"1343_CR56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/heartjnl-2016-309746","volume":"103","author":"M Chimura","year":"2016","unstructured":"Chimura M, Onishi T, Tsukishiro Y, Sawada T, Kiuchi K, Shimane A, et al. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy. Heart. 2016;103:679\u201386.","journal-title":"Heart."},{"key":"1343_CR57","doi-asserted-by":"crossref","unstructured":"Nielles-Vallespin S, Khalique Z, Ferreira PF, de Silva R, Scott AD, Kilner P, McGill LA, Giannakidis A, Gatehouse PD, Ennis D, Aliotta E, al-Khalil M, Kellman P, Mazilu D, Balaban RS, Firmin DN, Arai AE, Pennell DJ Assessment of myocardial microstructural dynamics by in vivo diffusion tensor cardiac magnetic resonance. J Am Coll Cardiol [Internet] 2017;69:661\u2013676. Available from: www.sciencedirect.com\/science?_ob=GatewayURL&_origin=IRSSSEARCH&_method=citationSearch&_piikey=S0735109716373272&_version=1&md5=908c4a2884a47eb567b64297df34c43c","DOI":"10.1016\/j.jacc.2016.11.051"},{"key":"1343_CR58","doi-asserted-by":"crossref","unstructured":"Khalique Z, Ferreira PF, Scott AD, Nielles-Vallespin S, Wage R, Firmin DN, et al. Diffusion tensor cardiovascular magnetic resonance of microstructural recovery in dilated cardiomyopathy. JACC Cardiovasc Imaging [Internet]. 2018; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1936878X18301360?dgcid=rss_sd_all","DOI":"10.1016\/j.jcmg.2018.01.025"},{"key":"1343_CR59","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jacc.2019.02.065","volume":"73","author":"R Ariga","year":"2019","unstructured":"Ariga R, Tunnicliffe EM, Manohar SG, Mahmod M, Raman B, Piechnik SK, et al. Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias. J Am Coll Cardiol. 2019;73:2493\u2013502.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR60","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1136\/heartjnl-2019-316033","volume":"106","author":"A De Marvao","year":"2020","unstructured":"De Marvao A, Dawes TJW, Howard JP, O\u2019Regan DP. Artificial intelligence and the cardiologist: what you need to know for 2020. Heart. 2020;106:2019\u201320.","journal-title":"Heart."},{"key":"1343_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2019-030833","volume":"9","author":"F Meng","year":"2019","unstructured":"Meng F, Zhang Z, Hou X, Qian Z, Wang Y, Chen Y, et al. Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China. BMJ Open. 2019;9:1\u20139.","journal-title":"BMJ Open"},{"key":"1343_CR62","doi-asserted-by":"publisher","unstructured":"De Ferrari GM, Sanzo A. T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: can it help to better select candidates for ICD implantation? Hear Rhythm [Internet]. Heart Rhythm Society; 2009;6:S29\u2013S35. https:\/\/doi.org\/10.1016\/j.hrthm.2008.10.008","DOI":"10.1016\/j.hrthm.2008.10.008"},{"key":"1343_CR63","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1540-8167.2010.01757.x","volume":"21","author":"PS Chan","year":"2010","unstructured":"Chan PS, Gold MR, Nallamothu BK. Do beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol. 2010;21:1009\u201314.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1343_CR64","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCEP.110.940478","volume":"3","author":"A Cheema","year":"2010","unstructured":"Cheema A, Khalid A, Wimmer A, Bartone C, Chow T, Spertus JA, et al. Fragmented QRS and mortality risk in patients with left ventricular dysfunction. Circ Arrhythmia Electrophysiol. 2010;3:339\u201344.","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"1343_CR65","doi-asserted-by":"publisher","unstructured":"Das MK, Maskoun W, Shen C, Michael MA, Suradi H, Desai M, et al. Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Hear Rhythm [Internet]. Elsevier Inc.; 2010;7:74\u201380. https:\/\/doi.org\/10.1016\/j.hrthm.2009.09.065","DOI":"10.1016\/j.hrthm.2009.09.065"},{"key":"1343_CR66","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2013.12.021","volume":"63","author":"JJ Goldberger","year":"2014","unstructured":"Goldberger JJ, Suba\u010dius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63:1879\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.101.1.40","volume":"101","author":"JR Teerlink","year":"2000","unstructured":"Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation. 2000;101:40\u20136.","journal-title":"Circulation."},{"key":"1343_CR68","doi-asserted-by":"publisher","unstructured":"Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation [Internet]. American Heart Association; 1996;94:3198\u2013203. Available from: https:\/\/doi.org\/10.1161\/01.CIR.94.12.3198.","DOI":"10.1161\/01.CIR.94.12.3198"},{"key":"1343_CR69","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1540-8159.2008.00988.x","volume":"31","author":"M Zecchin","year":"2008","unstructured":"Zecchin M, Di Lenarda A, Gregori D, Merlo M, Pivetta A, Vitrella G, et al. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? PACE - Pacing Clin Electrophysiol. 2008;31:290\u20139.","journal-title":"PACE - Pacing Clin Electrophysiol"},{"key":"1343_CR70","doi-asserted-by":"crossref","unstructured":"Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained tachycardia trial investigators. N Engl J Med [Internet]. 2000;342:1937\u201345. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10874061.","DOI":"10.1056\/NEJM200006293422602"},{"key":"1343_CR71","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0735-1097(98)00306-4","volume":"32","author":"W Grimm","year":"1998","unstructured":"Grimm W, Hoffmann J, Menz V, Luck K, Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol. 1998;32:739\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR72","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549","volume":"114","author":"MJ Shen","year":"2014","unstructured":"Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res. 2014;114:1004\u201321.","journal-title":"Circ Res"},{"key":"1343_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCIMAGING.115.004275","volume":"8","author":"JJ Goldberger","year":"2015","unstructured":"Goldberger JJ, Hendel RC. Decision making for implantable cardioverter defibrillator implantation: is there a role for neurohumoral imaging? Circ Cardiovasc Imaging. 2015;8:1\u20133.","journal-title":"Circ Cardiovasc Imaging."},{"key":"1343_CR74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0002-9149(01)02198-1","volume":"89","author":"A Ghuran","year":"2002","unstructured":"Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger JT, Camm AJ, et al. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (the autonomic tone and reflexes after myocardial infarction substudy). Am J Cardiol. 2002;89:184\u201390.","journal-title":"Am J Cardiol"},{"key":"1343_CR75","doi-asserted-by":"publisher","unstructured":"Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol [internet]. Elsevier Masson SAS; 1997;30:1009\u20131014. https:\/\/doi.org\/10.1016\/S0735-1097(97)00265-9","DOI":"10.1016\/S0735-1097(97)00265-9"},{"key":"1343_CR76","doi-asserted-by":"publisher","unstructured":"Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol [Internet]. Elsevier Masson SAS; 1999;33:1203\u20131207. https:\/\/doi.org\/10.1016\/S0735-1097(99)00021-2","DOI":"10.1016\/S0735-1097(99)00021-2"},{"key":"1343_CR77","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.0000100721.52503.85","volume":"108","author":"W Grimm","year":"2003","unstructured":"Grimm W, Christ M, Bach J, M\u00fcller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation. 2003;108:2883\u201391.","journal-title":"Circulation."},{"key":"1343_CR78","doi-asserted-by":"crossref","unstructured":"Doust JA, Pietrzak E, Dobson A, Glasziou PP. Papers events in patients with heart failure: systematic review 2005;330.","DOI":"10.1136\/bmj.330.7492.625"},{"key":"1343_CR79","doi-asserted-by":"publisher","unstructured":"McCarthy CP, Januzzi JL. Soluble ST2 in heart failure. Heart Fail Clin [Internet]. Elsevier Inc; 2018;14:41\u20138. https:\/\/doi.org\/10.1016\/j.hfc.2017.08.005.","DOI":"10.1016\/j.hfc.2017.08.005"},{"key":"1343_CR80","first-page":"1","volume":"13","author":"E Samuli Lepoj\u00e4rvi","year":"2018","unstructured":"Samuli Lepoj\u00e4rvi E, Huikuri HV, Piira OP, Kiviniemi AM, Miettinen JA, Kentt\u00e4 T, et al. Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study). PLoS One. 2018;13:1\u201311.","journal-title":"PLoS One"},{"key":"1343_CR81","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jacc.2009.07.041","volume":"54","author":"DA Pascual-Figal","year":"2009","unstructured":"Pascual-Figal DA, Ordo\u00f1ez-Llanos J, Tornel PL, V\u00e1zquez R, Puig T, Vald\u00e9s M, et al. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol. 2009;54:2174\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR82","doi-asserted-by":"publisher","unstructured":"Lup\u00f3n J, Cediel G, Moliner P, de Antonio M, Domingo M, Zamora E, et al. A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: the ST2-SCD score. Int J Cardiol [Internet]. Elsevier B.V.; 2019;293:148\u201352. https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.046.","DOI":"10.1016\/j.ijcard.2019.05.046"},{"key":"1343_CR83","doi-asserted-by":"publisher","unstructured":"Petretta M, Pirozzi F, Sasso L, Paglia A, Bonaduce D. Review and metaanalysis of the frequency of familial dilated cardiomyopathy. Am J Cardiol [Internet]. Elsevier Inc.; 2011;108:1171\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2011.06.022","DOI":"10.1016\/j.amjcard.2011.06.022"},{"key":"1343_CR84","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","volume":"141","author":"F Mazzarotto","year":"2020","unstructured":"Mazzarotto F, Tayal U, Buchan RJ, Midwinter W, Wilk A, Whiffin N, et al. Reevaluating the genetic contribution of monogenic dilated cardiomyopathy. Circulation. 2020;141:387\u201398.","journal-title":"Circulation."},{"key":"1343_CR85","doi-asserted-by":"publisher","unstructured":"Van Rijsingen IAW, Arbustini E, Elliott PM, Mogensen J, Hermans-Van Ast JF, Van Der Kooi AJ, et al. Risk factors for malignant ventricular arrhythmias in Lamin A\/C mutation carriers: a European cohort study. J Am Coll Cardiol [Internet]. Elsevier Inc.; 2012;59:493\u2013500. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.078","DOI":"10.1016\/j.jacc.2011.08.078"},{"key":"1343_CR86","doi-asserted-by":"crossref","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Bloma N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the Europea. Eur Heart J. 2015;36:2793-2867l.","DOI":"10.1093\/eurheartj\/ehv316"},{"key":"1343_CR87","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.jacc.2017.03.530","volume":"69","author":"U Tayal","year":"2017","unstructured":"Tayal U, Newsome S, Buchan R, Whiffin N, Walsh R, Barton PJ, et al. Truncating variants in Titin independently predict early arrhythmias in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2017;69:2466\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR88","doi-asserted-by":"crossref","unstructured":"Corden B, Jarman J, Whiffin N, Tayal U, Buchan R, Sehmi J, et al. Association of titin-truncating genetic variants with life-threatening cardiac arrhythmias in patients with dilated cardiomyopathy and implanted defibrillators. JAMA Netw Open. 2019;2.","DOI":"10.1001\/jamanetworkopen.2019.6520"},{"key":"1343_CR89","doi-asserted-by":"crossref","first-page":"e005220","DOI":"10.1161\/CIRCHEARTFAILURE.118.005220","volume":"11","author":"JAJ Verdonschot","year":"2018","unstructured":"Verdonschot JAJ, Hazebroek MR, Wang P, Sanders-van Wijk S, Merken JJ, Adriaansen YA, et al. Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy. Circ Heart Fail. 2018;11:e005220.","journal-title":"Circ Heart Fail"},{"key":"1343_CR90","doi-asserted-by":"crossref","unstructured":"Tayal U, Newsome S, Buchan R, Whiffin N, Halliday B, Lota A, et al. Phenotype and clinical outcomes of titin cardiomyopathy. J Am Coll Cardiol [Internet]. 2017 [cited 2018 Oct 9];70:2264\u201374. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29073955.","DOI":"10.1016\/j.jacc.2017.08.063"},{"key":"1343_CR91","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","volume":"68","author":"MF Ortiz-Genga","year":"2016","unstructured":"Ortiz-Genga MF, Cuenca S, Dal Ferro M, Zorio E, Salgado-Aranda R, Climent V, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol. 2016;68:2440\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR92","first-page":"326","volume":"21","author":"JB Augusto","year":"2020","unstructured":"Augusto JB, Eiros R, Nakou E, Moura-Ferreira S, Treibel TA, Captur G, et al. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study. Eur Heart J Cardiovasc Imaging. 2020;21:326\u201336.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1343_CR93","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","volume":"36","author":"A Bhonsale","year":"2015","unstructured":"Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JDH, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers. Eur Heart J. 2015;36:847\u201355.","journal-title":"Eur Heart J"},{"key":"1343_CR94","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/europace\/euu128","volume":"16","author":"JM L\u00f3pez-Ayala","year":"2014","unstructured":"L\u00f3pez-Ayala JM, G\u00f3mez-Milan\u00e9s I, Mu\u00f1oz JJ, Ruiz-Espejo F, Ort\u00edz M, Gonz\u00e1lez-Carrillo J, et al. Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. Europace. 2014;16:1838\u201346.","journal-title":"Europace."},{"key":"1343_CR95","doi-asserted-by":"crossref","unstructured":"\u2022 Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, et al. Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2019;74:1480\u201390. This study evaluated whether genetic variant carrier status can be used to enhance risk stratification of patients with DCM and demonstrated that desmosomal and LMNA gene variants identify patients at greatest risk for SCD and life-threatening ventricular arrhythmias irrespective of LVEF.","DOI":"10.1016\/j.jacc.2019.06.072"},{"key":"1343_CR96","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","volume":"16","author":"JA Towbin","year":"2019","unstructured":"Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Hear Rhythm. 2019;16:e301\u201372.","journal-title":"Hear Rhythm"},{"key":"1343_CR97","doi-asserted-by":"publisher","unstructured":"Groh WJ. Arrhythmias in the muscular dystrophies. Hear Rhythm [Internet]. Elsevier Inc.; 2012;9:1890\u20135. https:\/\/doi.org\/10.1016\/j.hrthm.2012.06.038","DOI":"10.1016\/j.hrthm.2012.06.038"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01343-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-020-01343-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01343-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T21:01:26Z","timestamp":1667336486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-020-01343-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":97,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1007\/s11886-020-01343-9","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"9 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"85"}}